Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Mallinckrodt
UBS
AstraZeneca
Fish and Richardson
Moodys
Covington
Queensland Health
Harvard Business School

Generated: February 24, 2018

DrugPatentWatch Database Preview

MEVACOR Drug Profile

« Back to Dashboard

When do Mevacor patents expire, and what generic alternatives are available?

Mevacor is a drug marketed by Merck and is included in one NDA.

The generic ingredient in MEVACOR is lovastatin. There are thirty-three drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the lovastatin profile page.

US Patents and Regulatory Information for MEVACOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck MEVACOR lovastatin TABLET;ORAL 019643-002 Mar 28, 1991 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck MEVACOR lovastatin TABLET;ORAL 019643-003 Aug 31, 1987 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck MEVACOR lovastatin TABLET;ORAL 019643-004 Dec 14, 1988 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for MEVACOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck MEVACOR lovastatin TABLET;ORAL 019643-002 Mar 28, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Merck MEVACOR lovastatin TABLET;ORAL 019643-003 Aug 31, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Merck MEVACOR lovastatin TABLET;ORAL 019643-004 Dec 14, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
US Department of Justice
Colorcon
Chubb
Johnson and Johnson
Merck
Accenture
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot